Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic drivers of disease.
The system analyses up to one million DNA letters at once to predict how mutations affect gene regulation.
AlphaGenome focuses on the non-coding genome, which controls when and where genes activate.
Researchers trained the model on large human and mouse genetics databases.
Scientists believe the tool could accelerate cancer research and rare disease diagnosis.
AlphaGenome may also support new gene therapies by helping design targeted DNA sequences.
Trending
- Saif al-Islam Gaddafi Killed in Western Libya
- U.S. Senate to Hold Landmark Hearing on Nazi-Era Swiss Bank Collaboration
- China Bans Hidden Door Handles to Improve Electric Vehicle Safety
- Sydney Scientists Recreate Cosmic Dust to Probe Origins of Life
- Trump Announces Tariff Cuts for India Amid Trade and Energy Talks
- Gold and silver tumble as investors abandon historic highs
- Soaring Shipping Costs Threaten Sharp Rise in Consumer Prices
- Alcaraz storms Melbourne and completes career Grand Slam
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in Chicago, USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He graduated with a degree in Journalism from the University of Florida. Over the years, he has contributed to leading outlets such as The New York Times, CNN, and Reuters. Recognized for his sharp reporting and thoughtful analysis, Andrew delivers accurate and timely news that keeps readers updated on key national and global developments.
Add A Comment